Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New collagen graft may boost bone for dental implants

NCT ID NCT04581304

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a collagen-based bone graft material (Bio-Oss Collagen) for sinus augmentation in people with bone loss and missing teeth. The goal is to see if it helps grow enough bone to support a dental implant. The study involves 36 adults who need a single implant in the upper jaw and have limited bone height.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Oct 2020

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients above the age of 18. * Patients with edentulous ridge maximal height of 8mm≥ beneath the maxillary sinus. * Patients with edentulous ridge minimal height of 3mm≤ beneath the maxillary sinus. * Patients who need single implant placement at the posterior maxilla. * Signed, well filled and dated informed consent form. Exclusion Criteria: * Inability to complete or understand the informed consent process. * Pregnant women. * Lactating women. * Patients who use medications that affect bone metabolism such as IV bisphosphonates. * Heavy smokers. * Patients with chronic/acute sinus infections

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bone loss are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rambam Health Care Campus, Dept. of Periodontology

    Haifa, 31096, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.